Stop Press - Pfizer And Ranbaxy Settle Lipitor Dispute (Mostly) Worldwide.
Mondaq Business Briefing › Nbr. 2008, March 2008
Linked as:
Extract
Stop Press - Pfizer And Ranbaxy Settle Lipitor Dispute (Mostly) Worldwide.
Well it looks as though all good things, including IP Scorecards must come to an end. Pfizer and Ranbaxy have decided to (mostly) settle the global lipitor patent battle. The Lipitor Scorecard has been updated, so go and have a look at the latest results...
See the full content of this document
Sponsored links
